ResMed Inc. (ASX: RMD)

Market Cap	56.67B
Revenue (ttm)	6.93B
Net Income (ttm)	1.61B
Shares Out	n/a
EPS (ttm)	10.87
PE Ratio	35.30
Forward PE	n/a
Dividend	0.46 (1.18%)
Ex-Dividend Date	Nov 6, 2024

Volume	311,548
Average Volume	610,143
Open	38.79
Previous Close	38.85
Day's Range	38.58 - 38.99
52-Week Range	26.61 - 39.13
Beta	0.69
RSI	62.69
Earnings Date	Jan 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: RMD

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD